Congenital left heart obstruction: ethnic variation in incidence and infant survival.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
09 2019
Historique:
received: 18 07 2018
revised: 01 02 2019
accepted: 01 02 2019
pubmed: 3 3 2019
medline: 17 3 2020
entrez: 3 3 2019
Statut: ppublish

Résumé

To investigate the relationship between ethnicity and health outcomes among fetuses and infants with congenital left heart obstruction (LHO). A retrospective population-based review was conducted of fetuses and infants with LHO including all terminations, stillbirths and live births from 20 weeks' gestation in New Zealand over a 9-year period. Disease incidence and mortality were analysed by ethnicity and by disease type: hypoplastic left heart syndrome (HLHS), aortic arch obstruction (AAO), and aortic valve and supravalvular anomalies (AVSA). Critical LHO was diagnosed in 243 fetuses and newborns. There were 125 with HLHS, 112 with AAO and 6 with isolated AVSA. The incidence of LHO was significantly higher among Europeans (0.59 per 1000) compared with Māori (0.31 per 1000; p<0.001) and Pacific peoples (0.27 per 1000; p=0.002). Terminations were uncommon among Māori and Pacific peoples. Total case fatality was, however, lower in Europeans compared with other ethnicities (42% vs 63%; p=0.002) due to a higher surgical intervention rate and better infant survival. The perinatal and infant mortality rate was 82% for HLHS, 15% for AAO and 2% for AVSA. HLHS carries a high perinatal and infant mortality risk. There are ethnic differences in the incidence of and mortality from congenital LHO with differences in mortality rate suggesting inequities may exist in the perinatal management pathway.

Identifiants

pubmed: 30824490
pii: archdischild-2018-315887
doi: 10.1136/archdischild-2018-315887
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

857-862

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Elza Cloete (E)

Liggins Institute, University of Auckland, Auckland, New Zealand.

Lynn Sadler (L)

Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.

Frank H Bloomfield (FH)

Liggins Institute, University of Auckland, Auckland, New Zealand.

Sue Crengle (S)

Department of Preventative and Social Medicine, University of Otago, Dunedin, New Zealand.

Teuila Percival (T)

Kidz First Children's Hospital, Auckland, New Zealand.

Thomas L Gentles (TL)

Greenlane Paediatric and Congenital Cardiac Service, Starship Hospital, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH